Top Section/Ad
Top Section/Ad
Most recent
Offer came as markets recovered and volatility fell
Abbott Laboratories plundered $20bn as it led a trio of drug companies which printed jumbo bonds as a deluge of supply in the dollar market ensured a red-hot end to the month.
Eight banks provided loan facility to company
More articles/Ad
More articles/Ad
More articles
-
Predictions range from zero premium for the highest grade credits to 75bp for high beta hybrids -
Outlooks have been challenged by a white swan event
-
Head European credit strategist says ECB unlikely to be blown off course by Omicron
-
During the summer, GlobalCapital surveyed capital markets professionals about how the pandemic has affected their work life, and what they expect to happen next. These are the results
-
Some issuers that have already carried out investor marketing may still seek to issue this year
-
Phoenix Pharma and Reno de Medici both forced into pushing back deals
